Dana-Farber Cancer Institute

Dana–Farber Cancer Institute is a comprehensive cancer treatment and research institution located in Boston, Massachusetts. It is the founding member of Dana–Farber/Harvard Cancer Center, which is Harvard’s Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.

As of 2023, Dana–Farber is ranked the #4 cancer hospital in the world. It has two Nobel laureates in Physiology or Medicine among its past and present faculty and its research discoveries include the development of the highly successful Gleevec to treat chronic myeloid leukemia. Dana–Farber employs more than 4,855 full-time and part-time people, 529 faculty, and has annual gross revenues of about $1,733,386,000. All faculty and postdoctoral research fellows at Dana–Farber hold the equivalent academic positions concurrently at Harvard University.

There are more than 523,425 adult and pediatric patient visits per year, and it is involved in more than 1,000 clinical trials. Expertscape ranks its programs in aplastic anemia and multiple myeloma as best in the world. It has been also ranked overall the fifth best cancer hospital in the United States by U.S. News & World Report. Dana–Farber is a member of the Multiple Myeloma Research Consortium. In addition to being a principal teaching affiliate of Harvard Medical School, Dana–Farber is also a federally designated Center for AIDS Research, and a founding member of the Dana–Farber/Harvard Cancer Center (DF/HCC), a federally designated Comprehensive Cancer Center.

Dana–Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and private foundations and individuals contributions. The Jimmy Fund is the principal charity of the Institute named for one of its child patients. The Boston Red Sox adopted the Jimmy Fund as its official charity in 1953 and continues to prominently sponsor the charity. Laurie Glimcher is the President/CEO of Dana–Farber Cancer Institute/Jimmy Fund. In 2015, Forbes listed the charity as the 37th biggest in the U.S.